788 filings
6-K
CSCI
COSCIENS Biopharma Inc.
23 Sep 24
COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs
7:30am
6-K
CSCI
COSCIENS Biopharma Inc.
27 Aug 24
COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
7:30am
6-K
CSCI
COSCIENS Biopharma Inc.
13 Aug 24
Current report (foreign)
8:05am
6-K
CSCI
COSCIENS Biopharma Inc.
13 Aug 24
COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results
8:05am
6-K
CSCI
COSCIENS Biopharma Inc.
6 Aug 24
Current report (foreign)
6:22pm
6-K
en28si hubbmaq
16 Jul 24
Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders
6:25pm
20-F/A
pb26wrdz9xnmjne5 c2l
16 Jul 24
Annual report (foreign) (amended)
6:22pm
6-K
5bywrj16f3e9g
25 Jun 24
Current report (foreign)
3:36pm
6-K
yisaigi28 hxoy5e
13 Jun 24
Company expects to report top-line data and complete study results in Q3 2024
9:20am
424B3
5pyw1k
10 Jun 24
Prospectus supplement
5:58pm
424B3
xff945k
10 Jun 24
Prospectus supplement
5:53pm
424B3
r9o4ip6
10 Jun 24
Prospectus supplement
5:50pm
424B3
74w 96sh8uv1uf
10 Jun 24
Prospectus supplement
5:48pm
6-K
ghyw9z108
10 Jun 24
Aeterna Zentaris and Ceapro Complete Merger Transaction
1:31pm
EFFECT
1w15 0g3jgijsznf
5 Jun 24
Notice of effectiveness
12:15am
EFFECT
m2cy9mo
5 Jun 24
Notice of effectiveness
12:15am
EFFECT
qj5rbnpp2o2t2j2i o0s
5 Jun 24
Notice of effectiveness
12:15am
S-8
7wvn10ewky
30 May 24
Registration of securities for employees
9:58pm
POS AM
6ev vhgr4ujg5jlc3qbn
30 May 24
Prospectus update (post-effective amendment)
9:56pm
POS AM
1h3a8ccsvsm
30 May 24
Prospectus update (post-effective amendment)
9:56pm